(0.28%) 5 113.98 points
(0.29%) 38 352 points
(0.34%) 15 981 points
(-1.05%) $82.97
(5.36%) $2.03
(0.29%) $2 354.10
(0.41%) $27.65
(4.35%) $962.20
(-0.26%) $0.932
(-0.43%) $10.98
(-0.57%) $0.796
(1.68%) $93.42
9.12% $ 3.71
@ $5.59
Emitido: 14 feb 2024 @ 13:54
Retorno: -33.66%
Señal anterior: feb 14 - 09:30
Señal anterior:
Retorno: 3.36 %
Live Chart Being Loaded With Signals
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally...
Stats | |
---|---|
Volumen de hoy | 1.98M |
Volumen promedio | 1.84M |
Capitalización de mercado | 386.64M |
EPS | $0 ( 2024-02-28 ) |
Próxima fecha de ganancias | ( $-0.660 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.970 |
ATR14 | $0.0120 (0.32%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-16 | Jordan Erica | Sell | 2 392 | Common Stock |
2024-03-15 | Sjuts Dustin S | Sell | 2 967 | Common Stock |
2024-03-18 | Sjuts Dustin S | Sell | 9 211 | Common Stock |
2024-03-15 | Moxie Dwight | Sell | 3 269 | Common Stock |
2024-03-18 | Moxie Dwight | Sell | 8 125 | Common Stock |
INSIDER POWER |
---|
64.41 |
Last 97 transactions |
Buy: 2 720 068 | Sell: 629 333 |
Volumen Correlación
Revance Therapeutics Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
SYKE | 0.944 |
SPRB | 0.923 |
BRACU | 0.922 |
XLRN | 0.921 |
PIRS | 0.918 |
ATCX | 0.918 |
MESA | 0.915 |
VRME | 0.915 |
JFIN | 0.913 |
OVID | 0.907 |
10 Correlaciones Más Negativas | |
---|---|
AHPI | -0.934 |
TUEM | -0.902 |
VERA | -0.881 |
ARDS | -0.865 |
CYTO | -0.86 |
NAKD | -0.852 |
LCAP | -0.85 |
CFV | -0.844 |
JRJC | -0.843 |
APM | -0.837 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Revance Therapeutics Inc Correlación - Moneda/Commodity
Revance Therapeutics Inc Finanzas
Annual | 2023 |
Ingresos: | $234.04M |
Beneficio Bruto: | $145.98M (62.38 %) |
EPS: | $-3.83 |
FY | 2023 |
Ingresos: | $234.04M |
Beneficio Bruto: | $145.98M (62.38 %) |
EPS: | $-3.83 |
FY | 2022 |
Ingresos: | $132.57M |
Beneficio Bruto: | $80.90M (61.03 %) |
EPS: | $-4.90 |
FY | 2021 |
Ingresos: | $77.80M |
Beneficio Bruto: | $54.39M (69.91 %) |
EPS: | $-4.17 |
Financial Reports:
No articles found.
Revance Therapeutics Inc
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing DaxibotulinumtoxinA in preclinical trial for the treatment of migraine, as well as a topical program for various indications; and OnabotulinumtoxinA, a biosimilar to BOTOX. The company has a collaboration and license agreement with Viatris Inc. to develop, manufacture, and commercialize onabotulinumtoxinA. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico